Filing Details
- Accession Number:
- 0001144519-21-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-02 19:08:51
- Reporting Period:
- 2021-02-26
- Accepted Time:
- 2021-03-02 19:08:51
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1495234 | Raul Padilla | C/O Bunge Ltd. 1391 Timberlake Manor Parkway Chesterfield MO 63017 | President, Global Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-26 | 5,000 | $71.20 | 104,846 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-26 | 5,000 | $76.88 | 99,846 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-28 | 43,380 | $0.00 | 143,226 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 12,200 | $71.20 | 155,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 12,200 | $77.67 | 143,226 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-02-26 | 5,000 | $71.20 | 5,000 | $71.20 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-01 | 12,200 | $0.00 | 12,200 | $71.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,300 | 2021-03-02 | No | 4 | M | Direct | |
| 1,100 | 2021-03-02 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $76.80 to $76.90. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Limited, any security holder of Bunge Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
- Represents common shares received on February 28, 2021 in settlement of performance-based restricted stock units ("PBRSUs") granted under the 2016 Bunge Limited Equity Incentive Plan, inclusive of a dividend reinvestment feature.
- This transaction was executed in multiple trades at prices ranging from $77.22 to $78.27. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Limited, any security holder of Bunge Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
- This option was exercisable in three equal installments beginning on March 2, 2012.
Billionaire Hedge Funds
